Submitted:
08 August 2024
Posted:
08 August 2024
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
2.1. Population
2.2. Measures
2.2.1. Outcome Variables
2.2.2. Independent Variables
- Economic Stability: Two items that constituted economic stability variables were annual income and employment status. The response was coded as “High” [1] and “Low” (0).
- Healthcare Access: Two items that constituted health access variables were: health insurance coverage and frequency of receiving care in the past 12 months. The response was coded as “High” (1) and “Low” (0).
- Food Security: Two items that constituted access to food variables included skipping meals and the ability to afford a balanced diet. The response was coded as “High” (2), “Medium (1), and “Low” (0).
- Social and Community Context: The social context variable (1 item) was discrimination when getting medical care because of race or ethnicity. The response was coded as “Yes” (1) and “No” (0).
- Neighborhood and Built Environment: Two items about the environment included access to transportation, medical appointments, work, or getting things needed for daily living, and the residential rural-urban community area zip code. The response was coded as “Urban” (1) and “Rural” (0).
- Education Access and Quality: Education access and quality were measured by two items: educational levels and health literacy. The educational levels were categorized into less than high school degree, high school degree, and greater than high school degree. Health literacy measures (3 items) were “knowledge about HPV,” “causes of cervical cancer,” and “knowledge of cervical cancer or HPV vaccine.” The response was coded as “Yes” (1) and “No” (0).
2.3. Covariates
2.4. Statistical Analysis
3. Results
3.1. Demographic Characteristics
3.2. Interest in Screening
3.3. Screening Behaviors
3.4. Impacts of SDOH and Psychosocial Factors on Interest in Screening
3.5. Impact of SDOH and Psychosocial Factors on Actual Screening Behavior
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- “Cervical Cancer Statistics | Key Facts About Cervical Cancer.” Accessed: Jun. 05, 2024. [Online]. Available: https://www.cancer.org/cancer/types/cervical-cancer/about/key-statistics.
- L. N. Fuzzell, R. B. Perkins, S. M. Christy, P. W. Lake, and S. T. Vadaparampil, “Cervical cancer screening in the United States: Challenges and potential solutions for underscreened groups,” Preventive Medicine, vol. 144, p. 106400, Mar. 2021. [CrossRef]
- A. Buskwofie, G. David-West, and C. A. Clare, “A Review of Cervical Cancer: Incidence and Disparities,” Journal of the National Medical Association, vol. 112, no. 2, pp. 229–232, Apr. 2020. [CrossRef]
- E. I. O. Garner, “Cervical Cancer: Disparities in Screening, Treatment, and Survival,” Cancer Epidemiology, Biomarkers & Prevention, vol. 12, no. 3, pp. 242s–247s, Mar. 2003.
- M. Matz, H. K. Weir, E. Alkhalawi, M. P. Coleman, and C. Allemani, “Disparities in cervical cancer survival in the United States by race and stage at diagnosis: An analysis of 138,883 women diagnosed between 2001 and 2014 (CONCORD-3),” Gynecologic Oncology, vol. 163, no. 2, pp. 305–311, Nov. 2021. [CrossRef]
- G. K. Singh, “Rural–Urban Trends and Patterns in Cervical Cancer Mortality, Incidence, Stage, and Survival in the United States, 1950–2008,” J Community Health, vol. 37, no. 1, pp. 217–223, Feb. 2012. [CrossRef]
- R. Landy, F. Pesola, A. Castañón, and P. Sasieni, “Impact of cervical screening on cervical cancer mortality: estimation using stage-specific results from a nested case–control study,” Br J Cancer, vol. 115, no. 9, pp. 1140–1146, Oct. 2016. [CrossRef]
- C. N. Bui et al., “Effect of Pap smear screening on cervical cancer stage at diagnosis: results from the Korean National Cancer Screening Program,” J Gynecol Oncol, vol. 32, no. 5, p. e81, Jun. 2021. [CrossRef]
- L. Niu, S. Virani, S. Bilheem, and H. Sriplung, “The effect of Pap smear screening on cervical cancer stage among southern Thai women,” Sci Rep, vol. 9, no. 1, p. 16921, Nov. 2019. [CrossRef]
- R. Landy et al., “Impact of screening on cervical cancer incidence: A population-based case–control study in the United States,” International Journal of Cancer, vol. 147, no. 3, pp. 887–896, 2020. [CrossRef]
- US Preventive Services Task Force et al., “Screening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement,” JAMA, vol. 320, no. 7, p. 674, Aug. 2018. [CrossRef]
- “Cervical Cancer Screening (PDQ®) - NCI.” Accessed: May 25, 2024. [Online]. Available: https://www.cancer.gov/types/cervical/hp/cervical-screening-pdq.
- M. Watson, V. Benard, J. King, A. Crawford, and M. Saraiya, “National assessment of HPV and Pap tests: Changes in cervical cancer screening, National Health Interview Survey,” Preventive Medicine, vol. 100, pp. 243–247, Jul. 2017. [CrossRef]
- A.Subramaniam et al., “Invasive cervical cancer and screening: what are the rates of unscreened and underscreened women in the modern era?,” J Low Genit Tract Dis, vol. 15, no. 2, pp. 110–113, Apr. 2011. [CrossRef]
- A. Bukowska-Durawa and A. Luszczynska, “Cervical cancer screening and psychosocial barriers perceived by patients. A systematic review,” Contemp Oncol (Pozn), vol. 18, no. 3, pp. 153–159, 2014. [CrossRef]
- V. Szabóová, S. V., and H. V., “Selected Risk Factors for Cervical Cancer and Barriers to Cervical Cancer Screening,” Acta Medica Martiniana, vol. 14, Jul. 2014. [CrossRef]
- S. P. Mckenna, “Predicting health behaviour: Research and practice with social cognition models: edited by Mark Conner and Paul Norman, Open university press, Buckingham, 1996. ISBN 0-335-19320-X. 230 pp. (pbk), price £14.99,” Safety Science, vol. 24, no. 3, pp. 229–230, Dec. 1996. [CrossRef]
- E. E. Tanner-smith and T. N. Brown, “Evaluating the Health Belief Model: A critical review of studies predicting mammographic and pap screening,” Social Theory & Health, vol. 8, no. 1, pp. 95–125, Feb. 2010. [CrossRef]
- S. S. Kurani et al., “Association of Neighborhood Measures of Social Determinants of Health With Breast, Cervical, and Colorectal Cancer Screening Rates in the US Midwest,” JAMA Netw Open, vol. 3, no. 3, p. e200618, Mar. 2020. [CrossRef]
- L. Williams-Brennan, D. Gastaldo, D. C. Cole, and L. Paszat, “Social determinants of health associated with cervical cancer screening among women living in developing countries: a scoping review,” Arch Gynecol Obstet, vol. 286, no. 6, pp. 1487–1505, Dec. 2012. [CrossRef]
- P. M. Lantz et al., “Socioeconomic disparities in health change in a longitudinal study of US adults: the role of health-risk behaviors,” Soc Sci Med, vol. 53, no. 1, pp. 29–40, Jul. 2001. [CrossRef]
- S. Bryant and W. Rakowski, “Predictors of mortality among elderly African-Americans,” Research on Aging, vol. 14, no. 1, pp. 50–67, 1992. [CrossRef]
- M. Asare, M. Flannery, and C. Kamen, “Social Determinants of Health: A Framework for Studying Cancer Health Disparities and Minority Participation in Research,” Oncol Nurs Forum, vol. 44, no. 1, pp. 20–23, Jan. 2017. [CrossRef]
- G. A. Benavidez, “Disparities in Meeting USPSTF Breast, Cervical, and Colorectal Cancer Screening Guidelines Among Women in the United States,” Prev. Chronic Dis., vol. 18, 2021. [CrossRef]
- C. R. Clark et al., “Addressing Social Determinants of Health to Improve Access to Early Breast Cancer Detection: Results of the Boston REACH 2010 Breast and Cervical Cancer Coalition Women’s Health Demonstration Project,” Journal of Women’s Health, vol. 18, no. 5, pp. 677–690, May 2009. [CrossRef]
- A. K. Lofters et al., “Using self-reported data on the social determinants of health in primary care to identify cancer screening disparities: opportunities and challenges,” BMC Fam Pract, vol. 18, no. 1, p. 31, Feb. 2017. [CrossRef]
- D. Nelson et al., “The Health Information National Trends Survey (HINTS): Development, Design, and Dissemination,” Journal of Health Communication, vol. 9, no. 5, pp. 443–460, Oct. 2004. [CrossRef]
- “Increase the proportion of females who get screened for cervical cancer — C-09 - Healthy People 2030 | health.gov.” Accessed: Jul. 12, 2024. [Online]. Available: https://health.gov/healthypeople/objectives-and-data/browse-objectives/cancer/increase-proportion-females-who-get-screened-cervical-cancer-c-09.
- L. R. B. Locklar and D. P. Do, “Rural-urban differences in HPV testing for cervical cancer screening,” The Journal of Rural Health, vol. 38, no. 2, pp. 409–415, 2022. [CrossRef]
- M. Akinlotan, J. N. Bolin, J. Helduser, C. Ojinnaka, A. Lichorad, and D. McClellan, “Cervical Cancer Screening Barriers and Risk Factor Knowledge Among Uninsured Women,” J Community Health, vol. 42, no. 4, pp. 770–778, Aug. 2017. [CrossRef]
- “Social determinants of health.” Accessed: May 27, 2024. [Online]. Available: https://www.who.int/health-topics/social-determinants-of-health.
- “2024 Phase 1 HP2030 Microsite Survey.” Accessed: May 27, 2024. [Online]. Available: https://survey.alchemer.com/s3/7793088/2024-Phase-1-HP2030-Microsite-Survey.
- CDC, “About National Breast and Cervical Cancer Early Detection Program,” National Breast and Cervical Cancer Early Detection Program. Accessed: Jul. 12, 2024. [Online]. Available: https://www.cdc.gov/breast-cervical-cancer-screening/about/index.html.
- K. Kim and H.-R. Han, “The Association Between Health Literacy and Breast and Cervical Cancer Screening Behaviors: Findings From the Behavioral Risk Factor Surveillance System,” Nursing Research, vol. 68, no. 3, p. 177, Jun. 2019. [CrossRef]
- R. Breitkopf, H. C. Pearson, and D. M. Breitkopf, “Poor Knowledge Regarding the Pap Test Among Low-Income Women Undergoing Routine Screening,” Perspectives on Sexual and Reproductive Health, vol. 37, no. 2, pp. 78–84, 2005. [CrossRef]
- H. Han et al., “Community-based health literacy focused intervention for cervical cancer control among Black women living with human immunodeficiency virus: A randomized pilot trial,” Health Expect, vol. 26, no. 1, pp. 172–182, Nov. 2022. [CrossRef]
- I. M. Rosenstock, “The Health Belief Model and Preventive Health Behavior,” Health Education Monographs, vol. 2, no. 4, pp. 354–386, Dec. 1974. [CrossRef]
- A. Groeppel-Klein, J. Helfgen, A. Spilski, and L. Schreiber, “The impact of age stereotypes on elderly consumers’ self-efficacy and cognitive performance,” Journal of Strategic Marketing, vol. 25, no. 3, pp. 211–225, Apr. 2017. [CrossRef]
- R. Suk, Y.-R. Hong, S. S. Rajan, Z. Xie, Y. Zhu, and J. C. Spencer, “Assessment of US Preventive Services Task Force Guideline–Concordant Cervical Cancer Screening Rates and Reasons for Underscreening by Age, Race and Ethnicity, Sexual Orientation, Rurality, and Insurance, 2005 to 2019,” JAMA Network Open, vol. 5, no. 1, p. e2143582, Jan. 2022. [CrossRef]
- M. L. Kasting, S. Wilson, T. W. Zollinger, B. E. Dixon, N. W. Stupiansky, and G. D. Zimet, “Differences in cervical cancer screening knowledge, practices, and beliefs: An examination of survey responses,” Preventive Medicine Reports, vol. 5, pp. 169–174, Mar. 2017. [CrossRef]
- M. Hewitt, S. S. Devesa, and N. Breen, “Cervical cancer screening among U.S. women: analyses of the 2000 National Health Interview Survey,” Preventive Medicine, vol. 39, no. 2, pp. 270–278, Aug. 2004. [CrossRef]
- “Practice Bulletin No. 168: Cervical Cancer Screening and Prevention,” Obstet Gynecol, vol. 128, no. 4, pp. e111–e130, Oct. 2016. [CrossRef]
- E. E. Zeno et al., “Racial and ethnic differences in cervical cancer screening barriers and intentions: The My Body My Test-3 HPV self-collection trial among under-screened, low-income women,” PLoS One, vol. 17, no. 10, p. e0274974, Oct. 2022. [CrossRef]
- J. C. Spencer et al., “Racial and Ethnic Disparities in Cervical Cancer Screening From Three U.S. Healthcare Settings,” American Journal of Preventive Medicine, vol. 65, no. 4, pp. 667–677, Oct. 2023. [CrossRef]
- L. Mann, K. L. Foley, A. E. Tanner, C. J. Sun, and S. D. Rhodes, “Increasing Cervical Cancer Screening Among US Hispanics/Latinas: A Qualitative Systematic Review,” J Cancer Educ, vol. 30, no. 2, pp. 374–387, Jun. 2015. [CrossRef]
- M. L. Jibaja-Weiss, R. J. Volk, Q. W. Smith, J. D. Holcomb, and P. M. (Paul M. Kingery, “Differential Effects of Messages for Breast and Cervical Cancer Screening,” Journal of Health Care for the Poor and Underserved, vol. 16, no. 1, pp. 42–52, 2005, Accessed: Jun. 18, 2024. [Online]. Available: https://muse.jhu.edu/pub/1/article/179459.
| Overall (n = 2,224) | Interest (n = 1,844) | Pap Test (n = 2,224) | |||
|---|---|---|---|---|---|
| n (%) | No n (%) |
Yes n (%) |
Overdue n (%) |
Current n (%) |
|
| Race | |||||
| Others | 164 (7.37%) | 43 (31.16%) | 95 (68.84) ** | 51 (31.10%) | 113 (68.90%) |
| Non-Hispanic Black or African American | 387 (17.40%) | 97 (31.49%) | 211 (68.51%) ** | 98 (25.32%) | 289 (74.68%) |
| Hispanic | 468 (21.04%) | 141 (36.06%) | 250 (63.94%) ** | 98 (20.94%) | 370 (79.06%) |
| Non-Hispanic Asian | 104 (4.68%) | 36 (38.71%) | 57 (61.29%) | 27 (25.96%) | 77 (74.04%) |
| Non-Hispanic White | 1101(49.51%) | 384 (42.01%) | 530 (57.99%) | 283 (25.70%) | 818 (74.30%) |
| Age Range | |||||
| 21 - 34 | 469 (21.09%) | 177 (43.17%) | 233 (56.83%) | 114 (24.31%) | 355 (75.69%) |
| 35 - 49 | 244 (10.97%) | 81 (38.03%) | 132 (61.97%) | 45 (18.44%) | 199 (81.56%) ** |
| 50 - 64 | 222 (9.98%) | 71 (37.97%) | 116 (62.03%) | 33 (14.86%) | 189 (85.14%) ** |
| 65 | 1289(57.96%) | 372 (35.98%) | 662 (64.02%) | 365 (28.32%) | 924 (71.68%) |
| Marital Status | |||||
| Not married | 1043(46.90%) | 330 (37.97%) | 539 (62.03%) | 302 (28.95%) | 741 (71.05%) |
| Married | 959 (43.12%) | 300 (38.17%) | 486 (61.83%) | 205 (21.38%) | 754 (78.62%) ** |
| Live with partner | 196 (8.81%) | 65 (38.69%) | 103 (61.31%) | 46 (23.47%) | 150 (76.53%) |
| Residential Area | |||||
| Rural | 432 (19.42%) | 177 (46.70%) | 202 (53.30%) | 157 (36.34%) | 275 (63.66%) |
| Urban | 1792(8058%) | 524 (35.77%) | 941 (64.23%) ** | 400 (22.32%) | 1392 (77.68%) ** |
| Cancer Type | |||||
| Gynecological | 45 (2.02%) | 8 (25.00%) | 24 (75.00%) | 17 (37.78%) | 28 (62.22%) |
| Breast Cancer | 57 (2.56%) | 14 (35.90%) | 25 (64.10%) | 15 (26.32%) | 42 (73.68%) |
| Gastrointestinal | 11 (0.49%) | 1 (12.50%) | 7 (87.50%) | 4 (36.36%) | 7 (63.64%) |
| Other | 94 (4.23%) | 19 (27.54%) | 50 (72.46%) | 18 (19.15%) | 76 (80.85%) |
| None | 1992(89.57%) | 653 (38.96%) | 1023 (61.04%) | 497 (24.95%) | 1495 (75.05%) |
| Number of People in Household | |||||
| One person | 525 (23.61%) | 170 (38.55%) | 271 (61.45%) | 155 (29.52%) | 370 (70.48%) |
| Two people | 744 (33.45%) | 225 (37.13%) | 381 (62.87%) * | 174 (23.39%) | 570 (76.61%) * |
| Three or more people | 955 (42.94%) | 306 (38.39%) | 491 (61.61%) | 228 (23.87%) | 727 (76.13%) * |
| Interest in screening | Screening behavior (Pap Test) | |||||
|---|---|---|---|---|---|---|
| AdjOR | 95% CI | p-value | AdjOR | 95% CI | p-value | |
| Social Determinants of Health | ||||||
| Health Literacy: | ||||||
| Low | 1.30 | 1.04 – 1.62 | 0.02 | 1.62 | 1.30 – 2.02 | 0.00 |
| High | 1.00 | 1.00 | ||||
| Healthcare access: | ||||||
| Low | 0.96 | 0.58 – 1.61 | 0.89 | 2.58 | 1.58 – 4.20 | 0.00 |
| High | 1.00 | 1.00 | ||||
| Access to food: | ||||||
| Low | 1.71 | 1.10 – 2.66 | 0.02 | 0.54 | 0.36 – 0.80 | 0.00 |
| Medium | 1.50 | 0.93 – 2.24 | 0.10 | 0.95 | 0.62 – 1.47 | 0.83 |
| High | 1.00 | 1.00 | ||||
| Economic Stability | ||||||
| Low | 1.37 | 1.01 – 1.86 | 0.05 | 1.40 | 1.05 – 1.89 | 0.02 |
| High | 1.00 | 1.00 | ||||
| Discrimination | ||||||
| No | 1.38 | 0.98 – 1.95 | 0.07 | 1.02 | 0.73 – 1.41 | 0.93 |
| Yes | 1.00 | 1.00 | ||||
| Residential Area | ||||||
| Rural | 1.59 | 1.26 – 2.00 | 0.00 | 1.96 | 1.55 – 2.46 | 0.00 |
| Urban | 1.00 | 1.00 | ||||
| Education | ||||||
| < High School Degree | 0.78 | 0.50 – 1.22 | 0.28 | 1.59 | 1.07 – 2.36 | 0.02 |
| High School Degree | 1.12 | 0.87 – 1.46 | 0.38 | 1.52 | 1.18 – 1.95 | 0.00 |
| >High School Degree | 1.00 | 1.00 | ||||
| Psychosocial Factors | ||||||
| Worry about getting cancer | ||||||
| Not at all | 10.03 | 7.08 – 14.23 | 0.00 | 1.44 | 1.06 – 1.96 | 0.02 |
| Somewhat | 2.70 | 2.10 – 3.47 | 0.00 | 1.09 | 0.86 – 1.38 | 0.47 |
| Agree | 1.00 | 1.00 | ||||
| Everything caused cancer | ||||||
| Disagree | 2.48 | 1.82 – 3.38 | 0.00 | 0.96 | 0.70 – 1.32 | 0.79 |
| Somewhat Agree | 1.66 | 1.30 – 2.12 | 0.00 | 0.98 | 0.77 – 1.26 | 0.89 |
| Agree | 1.00 | 1.00 | ||||
| Impossible to prevent cancer | ||||||
| Disagree | 0.93 | 0.62 – 1.38 | 0.70 | 0.72 | 0.50 – 1.06 | 0.10 |
| Somewhat | 0.86 | 0.60 – 1.24 | 0.42 | 0.68 | 0.48 – 0.97 | 0.03 |
| Agree | 1.00 | 1.00 | ||||
| Many recommendations cause confusion | ||||||
| Disagree | 1.28 | 0.88 – 1.87 | 0.20 | 0.89 | 0.61 – 1.30 | 0.55 |
| Somewhat | 0.98 | 0.77 – 1.25 | 0.89 | 0.89 | 0.70 – 1.13 | 0.34 |
| Agree | 1.00 | 1.00 | ||||
| Fatalism | ||||||
| Disagree | 1.61 | 1.15 – 2.24 | 0.00 | 0.69 | 0.49 – 0.95 | 0.02 |
| Somewhat | 1.26 | 0.99 – 1.60 | 0.06 | 0.78 | 0.62 – 0.99 | 0.04 |
| Agree | 1.00 | 1.00 | ||||
| Model 1 | Model 2 | Model 3 | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Variable | B | SE B | β | B | SE B | β | B | SE B | β |
| Covariates | |||||||||
| Age | 0.01 | 0.01 | 0.03 | 0.02 | 0.01 | 0.05 | 0.03 | 0.01 | 0.07** |
| Family History | 0.02 | 0.03 | 0.02 | 0.03 | 0.03 | 0.03 | 0.01 | 0.02 | 0.01 |
| Diagnosed | 0.07 | 0.10 | 0.03 | 0.10 | 0.10 | 0.04 | 0.01 | 0.10 | 0.00 |
| Cancer Type | 0.02 | 0.03 | 0.02 | 0.02 | 0.03 | 0.02 | -0.01 | 0.03 | -0.01 |
| Marital Status | 0.00 | 0.02 | 0.01 | 0.00 | 0.02 | 0.00 | -0.01 | 0.02 | -0.01 |
| Number of Household | 0.01 | 0.02 | 0.01 | 0.00 | 0.02 | 0.00 | 0.00 | 0.02 | 0.00 |
| Race | -0.03 | 0.01 | -0.09 | -0.03 | 0.01 | -0.09 | -0.05 | 0.01 | -0.13** |
| Social Determinants | |||||||||
| Health Literacy | 0.06 | 0.03 | 0.06 | 0.03 | 0.03 | 0.03 | |||
| Access to Healthcare | 0.00 | 0.07 | 0.00 | -0.01 | 0.07 | 0.00 | |||
| Access to Food | 0.05 | 0.02 | 0.06 | 0.04 | 0.02 | 0.04 | |||
| Economic Stability | 0.10 | 0.04 | 0.07* | 0.09 | 0.04 | 0.06* | |||
| Residential Area | 0.11 | 0.03 | 0.09* | 0.09 | 0.03 | 0.07** | |||
| Education | -0.04 | 0.03 | -0.04 | -0.02 | 0.02 | -0.03 | |||
| Psychosocial Factors | |||||||||
| Worried | 0.24 | 0.02 | 0.32** | ||||||
| Cause cancer | 0.03 | 0.02 | 0.03 | ||||||
| Impossible to prevent | -0.04 | 0.02 | -0.04 | ||||||
| Recommendation | 0.02 | 0.03 | 0.03 | ||||||
| Fatalism | -0.02 | 0.02 | -0.03 | ||||||
| R2 | 0.01 | 0.03 | 0.13 | ||||||
| F for change in R2 | 0.010** | 0.019** | 0.107** | ||||||
| Model 1 | Model 3 | Model 3 | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Variable | B | SE B | β | B | SE B | β | B | SE B | β |
| Covariates | |||||||||
| Age | -0.02 | 0.01 | -0.05 | -0.02 | 0.01 | -0.04 | -0.01 | 0.01 | -0.04 |
| Family History | -0.03 | 0.02 | -0.04 | -0.02 | 0.02 | -0.03 | -0.03 | 0.02 | -0.03 |
| Diagnosed | 0.16 | 0.08 | 0.07 | 0.15 | 0.08 | 0.07 | 0.14 | 0.08 | 0.06 |
| Cancer Type | 0.04 | 0.03 | 0.05 | 0.03 | 0.03 | 0.04 | 0.03 | 0.03 | 0.03 |
| Marital Status | 0.04 | 0.02 | 0.06 | 0.04 | 0.02 | 0.06 | 0.03 | 0.02 | 0.05 |
| Number of Household | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 | 0.02 |
| Race | -0.01 | 0.01 | -0.02 | -0.01 | 0.01 | -0.03 | -0.01 | 0.01 | -0.04 |
| Social Determinants | |||||||||
| Health Literacy | 0.08 | 0.02 | 0.08 | 0.08 | 0.02 | 0.08** | |||
| Access to Healthcare | 0.14 | 0.06 | 0.06 | 0.14 | 0.06 | 0.05* | |||
| Access to Food | -0.04 | 0.02 | -0.06 | -0.05 | 0.02 | -0.06* | |||
| Economic Stability | 0.04 | 0.03 | 0.03 | 0.04 | 0.03 | 0.03 | |||
| Residential Area | 0.11 | 0.03 | 0.10 | 0.10 | 0.03 | 0.10** | |||
| Education | 0.01 | 0.02 | 0.01 | 0.01 | 0.02 | 0.02 | |||
| Psychosocial Factors | |||||||||
| Worried | 0.06 | 0.02 | 0.08** | ||||||
| Cause cancer | -0.01 | 0.02 | -0.02 | ||||||
| Impossible to prevent | 0.03 | 0.02 | 0.03 | ||||||
| Recommendation | -0.01 | 0.02 | -0.01 | ||||||
| Fatalism | -0.04 | 0.02 | -0.05* | ||||||
| R2 | 0.01 | 0.04 | 0.05 | ||||||
| F for change in R2 | 0.013** | 0.029** | 0.007** | ||||||
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
